Medication adherence strategies for drug abusers with HIV/AIDS

AIDS Care - Psychological and Socio-Medical Aspects of AIDS/HIV

Volumn 10, Issue 3, 1998, Pages 297-312

  Sorensen, J L ^a,b   Mascovich, A ^b   Wall, T L ^b   Dephilippis, D ^b   Batki, S L ^a,b   Chesney, M ^b  

^a SAN FRANCISCO GENERAL HOSPITAL   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; METHADONE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; CLINICAL ARTICLE; DRUG DEPENDENCE; FEMALE; HEALTH PROGRAM; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; METHADONE TREATMENT; PATIENT CARE; PATIENT COMPLIANCE; PRIORITY JOURNAL;

EID: 0031833154     PISSN: 09540121     EISSN: None     Source Type: Journal    
DOI: 10.1080/713612419     Document Type: Article

References (50)

1. BATKI, S.L., LONDON, J., GOOSBY, E., CLEMENT, M., WOLFE, R., RYAN, C., FRENCH, D., YOUNG, M., MILLER, D., CHRISTMAS, R. & SORENSEN, J.L. (1990). Medical care for intravenous drug users with AIDS and ARC: Delivering services at a methadone treatment program. Paper presented at the VI International Conference on AIDS, San Francisco.
2. BELL, R.L., CURB, J.D. & FRIEDMAN, L.M. (1985). Enhancement of visit adherence in the National Beta-Blocker Heart Attack Trial. Controlled Clinical Trials, 6, 89-101.
3. BLUMENTHAL, J.A., WILLIAMS, R.S., WALLACE, A.G., WILLIAMS, R.B. & NEEDLES, T.L. (1982). Physiological and psychological variables predict compliance to prescribed exercise therapy in patients recovering from myocardial infarction. Psychosomatic Medicine, 44, 519-527.
4. BRETTLE, R.P., WILLOCKS, L., HAMILTON, B.A., SHAW, L., LEEN, C.L., RICHARDSON, A. & GORE, S.M. (1994). Outpatient medical care in Edinburgh for IDU-related HIV. AIDS Care, 6, 49-58.
5. BROERS, B., MORABIA, A. & HIRSCHEL, B. (1994). A cohort study of drug users' compliance with zidovudine treatment. Archives of Internal Medicine, 154, 1121-1127.
6. CAMINERO, J.A., PAVON, J.M., RODRIGUEZ DE CASTRO, F., DIAZ, F., JULIA, G., CAYLA, J.A. & CABRERA, P. (1996). Evaluation of a directly observed six months fully intermittent treatment regimen for tuberculosis in patients suspected of poor compliance. Thorax, 51, 1130-1133.
7. CARPENTER, C.C., FISCHI, M.A., HAMMER, M.D., HIRSCH, M.S., JACOBSEN, D.M., KATZENSTEIN, D.A., MONTANER, J.S., RICHMAN, D.D., SAAG, M.S., SCHOOLEY, R.T., THOMPSON, M.A., VELLA, S., YENI, P.G. & VOLBERDING, P.A. (1996). Consensus statement: antiretroviral therapy for HIV infection in 1996: recommendations of an international panel. JAMA, 276, 146-154.
8. CARTHEW, D. & STYRES, K. (1993). The effect of homelessness on compliance with medical regimens [letter]. Nurse Practitioner, 18(12), 8, 11.
9. Centers for Disease Control and Prevention (1993a). 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. Journal of the American Medical Association, 269, 729-730.
10. Center for Disease Control and Prevention (1993b). Tuberculosis prevention in drug-treatment centers and correctional facilities - selected US sites, 1990-1991. Morbidity and Mortality Weekly Report, 42, 210-213.
11. Centers for Disease Control and Prevention (1996). HIV/AIDS surveillance report, 8(2).
12. CHESNEY, M.A., LURIE, P. & COATES, T.J. (1995). Strategies for addressing the social and behavioral challenges of prophylactic HIV vaccine trials. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology, 9, 30-35.
13. CURTIS, R., FRIEDMAN, S.R., NEAIGUS, A., JOSE, B., GOLDSTEIN, M. & DES JARLAIS, D.C. (1994). Implications of directly observed therapy in tuberculosis control measures among IDUs. Public Health Reports, 109, 319-327.
14. DEEKS, S.G., SMITH, M., HOLODNIY, M. & KAHN, J.O. (1997). HIV-1 protease inhibitors: a review for clinicians. JAMA, 277, 145-153.
15. DENOON, D.J. (1996). Commentary: Protease inhibitors: the good and the bad. AIDS Weekly, 19 August, 3-5.
16. DUNBAR, J. (1990). Predictors of patient adherence: patient characteristics. In: S.A. SHUMAKER, E.B. SCHRON & J.K. OCKENE senior (Eds), The handbook of health behavior change (pp. 348-360). New York: Springer.
17. DUNBAR, J., KNOKE, J. & HOOGWERF, B. (1990). Prediction of medication adherence at one year and seven years: behavioral and psychological factors. Lipid Research Clinics Trial Report. Pittsburgh: University of Pittsburgh, National Heart, Lung, and Blood Institute.
18. EASTERBROOK, P.J., KERULY, J.C., CREAGH-KIRK, T., RICHMAN, D.D., CHAISSON, R.E. & MOORE, R.D. (1991). Racial and ethnic differences in outcome in zidovudine-treated patients with advanced HIV disease. Zidovudine Epidemiology Study Group. JAMA, 266, 2713-2718.
19. ELDRED, L.J., WU, A., CHAISSON, R.E. & MOORE, R.D. (1996). Medication adherence to long-term therapy in HIV disease. Poster presentation at the XI International Conference on AIDS, Vancouver, BC.
20. ELK, R., GRABOWSKI, J., RHOADES, H., SPIGA, R., SCHMITZ, J. & JENNINGS, W. (1993). Compliance with tuberculosis treatment in methadone-maintained patients: behavioral interventions. Journal of Substance Abuse Treatment, 10, 371-382.
21. EPSTEIN, L.H. & CLUSS, P.A. (1982). A behavioral medicine perspective on adherence to long-term medical regimens. Journal of Consulting and Clinical Psychology, 50, 950-971.
22. FISCHL, M.A. (1991). Adherence in the safety and efficacy study of zidovudine in the treatment of subjects with mildly symptomatic HIV. Paper presented at the Conference of Adherence in AIDS Clinical Trials, San Francisco, CA.
23. GOOSBY, E., BATKI, S.L., LONDON, J., FERRANDO, S.J., RYAN, C., HARTWIG, R. & ABBOTT, C. (1992). Medical care of HIV disease in methadone maintenance treatment. In: L.S. HARRIS (Ed.), Problems of drug dependence 1991: Proceedings of the 53rd annual scientific meeting, the Committee on the Problems of Drug Dependence, Inc. (p. 431). (NIDA Research Monograph Series 119, DHHS Pub. No. (ADM) 92-1888). Washington, DC: US Government Printing Office.
24. GOUREVITCH, M.N., WASSERMAN, W., PANERO, M.S. & SELWYN, P.A. (1996). Successful adherence to observed prophylaxis and treatment of tuberculosis among drug users in a methadone program. Journal of Addictive Diseases, 15, 93-104.
25. HAYDEN, C.H., JEREB, J., DOOLEY, S., STERN, H. & SEAWRIGHT, M. (1991). HIV-related tuberculosis prevention in drug treatment centers and correctional facilities. Paper (ThC93) presented at the VII International Conference on AIDS, Florence, Italy.
26. HAYNES, R.B., MCKIBBON, K.A. & KANANI, R. (1996). Systematic review of randomised trials of interventions to assist patients to follow prescriptions for medications. Lancet, 348, 383-386.
27. HOLMBERG, S.D. (1996). The estimated prevalence and incidence of HIV in 96 large US metropolitan areas. American Journal of Public Health, 86, 642-654.
28. JOHNS HOPKINS University AIDS Service (1997). Update on HIV management. The Hopkins HIV Report, 9(2, Suppl.), 1-11.
29. KIRSCHT, J.P., KIRSCHT, J.L. & ROSENSTOCK, I.M. (1981). A test of interventions to increase adherence to hypertensive medical regimens. Health Education Quarterly, 8, 261.
30. LAGAKOS, S., FISCHL, M.A., STEIN, D.S., LIM, L. & VOLBERDING, P. (1991). Effects of zidovudine therapy in minority and other sub-populations with early HIV infection. JAMA, 266, 2709-2712.
31. MARSTON, W.V. (1970). Compliance with medical regimens: a review of the literature. Nursing Research, 19, 312-323.
32. MAYO, K., WHITE, S., OATES, S.K. & FRANKLIN, F. (1996). Community collaboration: prevention and control of tuberculosis in a homeless shelter. Public Health Nursing, 13, 120-127.
33. MEICHENBAUM, D. & TURK, C. (1987). Facilitating treatment adherence: a practitioner's guidebook. New York: Plenum Press.
34. MORSE, E.V., SIMON, P.M., COBURN, M., HYSLOP, N., GREENSPAN, D. & BALSON, P.M. (1991). Determinants of subject compliance within an experimental anti-HIV drug protocol. Social Science and Medicine, 32(10), 1161-1167.
35. PERLMAN, D.C., PERKINS, M.P., SOLOMON, N., KOCHEMS, L., DES JARLAIS, D.C. & PAONE, D. (1997). Tuberculosis screening at a syringe exchange program. American Journal of Public Health, 77, 862-863.
36. PROBSTFIELD, J.L. (1989). Adherence and its management in clinical trials: implications for arthritis treatment trials. Arthritis Care and Research, 2(3), S48-S57.
37. RICHMAN, D.D., FISCHL, M.A., GRIECO, M.H., GOTTLEIB, M.S., VOLBERDING, P.K., LASKIN, O.L., LEEDON, J.M., GROOPMAN, J.E., MILDVAN, D., HIRSCH, M.S., JACKSON, G.G., DURAK, D.T. & NURINOFF-LEHRMAN, S. (1987). The toxicity of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. New England Journal of Medicine, 317, 192-197.
38. SAMET, J.H., LIBMAN, H., STEGER, K.A., DHAWAN, R.K., CHEN, J., SHEVITZ, A.H., DEWEES-DUNK, R., LEVENSON, S., KUFE, D. & CRAVEN, D.E. (1992). Compliance with zidovudine therapy in patients infected with human immunodeficiency virus, type I: a cross-sectional study in a municipal hospital clinic. American Journal of Medicine, 92, 495-502.
39. SELL, L., FINCH, E., FARRELL, M., SHERIDAN, J. & STRANG, J. (1996). Directly observed treatment for tuberculosis. Could be provided by community pharmacists supervising consumption of methadone [letter]. British Medical Journal, 313, 45.
40. SELWYN, P.A., FEINGOLD, A.R., IEZZA, A., SATYADEO, M., COLLEY, J., TORRES, R. & SHAW, J.F. (1989). Primary care for patients with human immunodeficiency virus (HIV) infection in a methadone maintenance treatment program. Annals of Internal Medicine, 111, 761-763.
41. SMITH, D.M., WEINBERGER, M. & KATZ, B.P. (1987). A controlled trial to increase office visits and reduce hospitalizations of diabetic patients. Journal of General Internal Medicine, 2, 231-237.
42. SONTAG, D. & RICHARDSON, L. (1997). Doctors withhold HIV pill regimen from some; failure to follow rigid schedule could hurt others, they fear (human immunodeficiency virus treatment complicated by ability of patients stay on schedule). New York Times, 146, (section 1), 1.
43. SORENSEN, J.L. & BATKI, S.L. (1992). Management of psychosocial sequelae of HIV infection among drug abusers. In: J.H. LOWINSON, P. RUIZ & R.R. MILLMAN (Eds), Comprehensive textbook of substance abuse (pp. 788-792). BALTIMORE: WILLIAMS & WILKINS.
44. SORENSEN, J.L., BATKI, S.L., LONDON, J.A., DEPHILIPPIS, D., MASCOVICH, A. & WALL, T.A. (1995). Medication adherence requirements for IDUs with HIV disease. In: L.S. HARRIS (Ed.), Problems of drug dependence: 1994: Proceedings of the 56th annual scientific meeting, the College on the Problems of Drug Dependence, Inc., Volume II (p. 443) (NIDA Research Monograph 154, NIH Pub. No. 95-3883). Washington, DC: US Government Printing Office.
45. SORENSEN J.L., DEPHILIPPIS, D., WALL, T.L., ENDERS-ZOHR, P., BATKI, S.L., CHESNEY, M., LONDON, J., GJEDSTED, V. & MASCOVICH, A. (1994). Improving adherence to Medication. San Francisco: SFGH Substance Abuse Services, Department of Psychiatry, University of California at San Francisco.
46. SORENSEN, J.L., MASCOVICH, A., BATKI, S.L., KRUGER, B. & WALL, T.A. (1996). Management of HIV medications in methadone treatment. In: L.S. HARRIS (Ed.), Problems of drug dependence: 1995: Proceedings of the 57th annual scientific meeting, the College on the Problems of Drug Dependence Inc. (p. 213) (NIDA Research Monograph 162, NIH Pub. No. 96-4116). Rockville, MD: US Department of Health and Human Services.
47. WALL, T.L., SORENSEN, J.L., BATKI, S.L., DELUCCHI, K.L., LONDON, J.A. & CHESNEY, M.A. (1995). Adherence to zidovudine (AZT) among HIV-infected methadone patients: a pilot study of supervised therapy and dispensing compared to usual care. Drug and Alcohol Dependence, 37, 261-269.
48. WALL, T.L., SORENSEN, J.L., LONDON, J., DELUCCHI, K.L., FERRANDO, S.J., ABBOTT, C., MORRIS, P. & BATKI, S.L. (1993). Adherence to zidovudine (AZT) in HIV-infected injection drug users [abstract]. In: L.S. HARRIS (Ed.), Problems of drug dependence: 1992: Proceedings of the College on the Problems of Drug Dependence, Inc. (p. 292) (NIDA Research Monograph 132, NIH Pub. No. 93-3505). Washington, DC: US Government Printing Office.
49. WHALEN, C., HORSBURGH, C.R., HOM, D., LAHART, C., SIMBERKOFF, M. & ELLNER, J. (1995). Accelerated course of human immunodeficiency virus infection after tuberculosis. American Journal of Respiratory and Critical Care Medicine, 151, 129-135.
50. WORLD HEALTH ORGANIZATION (1997). HIV/AIDS: the global epidemic, December 1996. Weekly Epidemiological Record, 72, 17-21.